title: Doxofylline and methylprednisolone sodium succinate are stable and compatible under normal injection conditions.
abstract: To assess the physical compatibility and chemical stability of doxofylline with methylprednisolone sodium succinate in 0.9% sodium chloride or 5% dextrose injection for intravenous infusion. Twenty mL doxofylline solution (0.74 mg/mL) and 1 mL methylprednisolone sodium succinate solution (0.15 mg/mL) were added into 250 mL polyolefin bags containing 5% dextrose injection or 0.9% sodium chloride injection, and stored for 24 h at 20-25(°)C. Chemical compatibility was measured with high-performance liquid chromatography (HPLC), and physical compatibility was determined visually. The results showed that samples were clear and colorless when viewed in normal fluorescent room light. The pH value exhibited little change. The particulate content of > 25 μm was low and within the specification limit. The particulate content of > 10 μm decreased over time and was similar to the control solution. Analysis of chemical stability revealed that doxofylline is stable with methylprednisolone sodium succinate for up to 24 h, and the degradation of methylprednisolone sodium succinate is unrelated to doxofylline, but is closely related to the pH value of the solution. Doxofylline and methylprednisolone sodium succinate did not affect the stability of each other.
authors: Chinese Military, Kunming, Yunnan, China. xu_fan@126.com
authors: Fan
authors: F
authors: Xu
authors: Enfu
authors: E
authors: Feng
authors: Li
authors: L
authors: Su
authors: Guili
authors: G
authors: Xu
mesh_terms: D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D003116:Color; D004338:Drug Combinations; D004339:Drug Compounding; D004355:Drug Stability; D004356:Drug Storage; D005938:Glucocorticoids / Q000008:administration & dosage / Q000737:chemistry*; D005947:Glucose / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D007262:Infusions, Intravenous; D007267:Injections; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage / Q000737:chemistry*; D019999:Pharmaceutical Solutions; D012965:Sodium Chloride / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000379:methods; D013696:Temperature; D013806:Theophylline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry; D013997:Time Factors
chemical_list: D001993:Bronchodilator Agents; D004338:Drug Combinations; D005938:Glucocorticoids; D019999:Pharmaceutical Solutions; D012965:Sodium Chloride; D008776:Methylprednisolone Hemisuccinate; D013806:Theophylline; D005947:Glucose; C029797:doxofylline